Richter Sundberg Linda, Garvare Rickard, Nyström Monica Elisabeth
Department of Public Health and Clinical Medicine, Epidemiology and Global Health, Umeå University, SE 901 87, Umeå, Sweden.
Department of Clinical Science, Child and Adolescent Psychiatry, Umeå University, SE 901 87, Umeå, Sweden.
BMC Health Serv Res. 2017 May 11;17(1):344. doi: 10.1186/s12913-017-2277-1.
The judgment and decision making process during guideline development is central for producing high-quality clinical practice guidelines, but the topic is relatively underexplored in the guideline research literature. We have studied the development process of national guidelines with a disease-prevention scope produced by the National board of Health and Welfare (NBHW) in Sweden. The NBHW formal guideline development model states that guideline recommendations should be based on five decision-criteria: research evidence; curative/preventive effect size, severity of the condition; cost-effectiveness; and ethical considerations. A group of health profession representatives (i.e. a prioritization group) was assigned the task of ranking condition-intervention pairs for guideline recommendations, taking into consideration the multiple decision criteria. The aim of this study was to investigate the decision making process during the two-year development of national guidelines for methods of preventing disease.
A qualitative inductive longitudinal case study approach was used to investigate the decision making process. Questionnaires, non-participant observations of nine two-day group meetings, and documents provided data for the analysis. Conventional and summative qualitative content analysis was used to analyse data.
The guideline development model was modified ad-hoc as the group encountered three main types of dilemmas: high quality evidence vs. low adoptability of recommendation; insufficient evidence vs. high urgency to act; and incoherence in assessment and prioritization within and between four different lifestyle areas. The formal guideline development model guided the decision-criteria used, but three new or revised criteria were added by the group: 'clinical knowledge and experience', 'potential guideline consequences' and 'needs of vulnerable groups'. The frequency of the use of various criteria in discussions varied over time. Gender, professional status, and interpersonal skills were perceived to affect individuals' relative influence on group discussions.
The study shows that guideline development groups make compromises between rigour and pragmatism. The formal guideline development model incorporated multiple aspects, but offered few details on how the different criteria should be handled. The guideline development model devoted little attention to the role of the decision-model and group-related factors. Guideline development models could benefit from clarifying the role of the group-related factors and non-research evidence, such as clinical experience and ethical considerations, in decision-processes during guideline development.
临床实践指南制定过程中的判断和决策对于产生高质量的临床实践指南至关重要,但该主题在指南研究文献中相对未得到充分探讨。我们研究了瑞典国家卫生和福利委员会(NBHW)制定的具有疾病预防范围的国家指南的制定过程。NBHW的正式指南制定模型指出,指南建议应基于五个决策标准:研究证据;治疗/预防效果大小、病情严重程度;成本效益;以及伦理考量。一组卫生专业代表(即一个优先排序小组)被赋予了一项任务,即在考虑多个决策标准的情况下,对指南建议的疾病干预对进行排序。本研究的目的是调查为期两年的国家疾病预防方法指南制定过程中的决策过程。
采用定性归纳纵向案例研究方法来调查决策过程。问卷、对九次为期两天的小组会议的非参与观察以及文件为分析提供了数据。采用常规和总结性定性内容分析来分析数据。
随着小组遇到三种主要类型的困境,指南制定模型被临时修改:高质量证据与建议的低可采纳性;证据不足与行动的高度紧迫性;以及四个不同生活方式领域内部和之间评估与优先排序的不一致。正式的指南制定模型指导了所使用的决策标准,但小组增加了三个新的或修订的标准:“临床知识和经验”、“潜在的指南后果”和“弱势群体的需求”。在讨论中各种标准的使用频率随时间而变化。性别、专业地位和人际技能被认为会影响个人对小组讨论的相对影响力。
该研究表明,指南制定小组在严谨性和务实性之间做出了妥协。正式的指南制定模型纳入了多个方面,但在如何处理不同标准方面提供的细节很少。指南制定模型很少关注决策模型和与小组相关因素的作用。指南制定模型可以从明确与小组相关因素和非研究证据(如临床经验和伦理考量)在指南制定决策过程中的作用中受益。